Showing 1 posts of 1 posts found.
Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
Ondine reports 40% reduction in surgical-site infections in phase 3 trial
Northern Ireland to roll out staff well-being training across health service
European consortium demonstrates continuous manufacturing platform for pharmaceutical ingredients